Updated Jul 16, 2026
Stout Jay S has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.24M.
Jay S. Stout is the Chief Technology Officer at Immunovant, Inc., a clinical-stage immunology company focused on autoimmune diseases. He has been involved in multiple SEC filings related to his role at the company.
| Role | Chief Technology Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 77 | $39.99 | $3K |
| 2026-07-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.4K | $39.53 | $55K |
| 2026-07-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 105 | $39.99 | $4K |
| 2026-07-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.9K | $39.53 | $75K |
| 2026-06-26 | IMVT | Immunovant, Inc. | S — Open-market sale | 6.7K | $38.94 | $262K |
| 2026-06-26 | IMVT | Immunovant, Inc. | S — Open-market sale | 33.3K | $38.18 | $1.27M |
| 2026-04-24 | IMVT | Immunovant, Inc. | S — Open-market sale | 2.8K | $29.62 | $82K |
| 2026-04-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.5K | $24.83 | $38K |
| 2026-04-10 | IMVT | Immunovant, Inc. | S — Open-market sale | 8.6K | $24.83 | $214K |
| 2026-04-09 | IMVT | Immunovant, Inc. | A — Grant or award | 66.9K | $0.00 | |
| 2026-01-23 | IMVT | Immunovant, Inc. | S — Open-market sale | 2.0K | $26.03 | $51K |
| 2025-10-08 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.6K | $16.30 | $26K |
| 2025-07-23 | IMVT | Immunovant, Inc. | S — Open-market sale | 2.8K | $18.15 | $51K |
| 2025-07-09 | IMVT | Immunovant, Inc. | S — Open-market sale | 1.5K | $17.24 | $26K |
| 2024-10-25 | IMVT | Immunovant, Inc. | S — Open-market sale | 2.7K | $29.53 | $81K |
Jay S. Stout is the Chief Technology Officer at Immunovant, Inc., a clinical-stage immunology company focused on autoimmune diseases. He has been involved in multiple SEC filings related to his role at the company.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 14 open-market sales ($2.24M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Stout Jay S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.